Pharmaceutical Executive November 5, 2024
The latest news for pharma industry insiders.
A Strategic Look at FDA’s Diversity Action Plan Guidance
In a video interview with Applied Clinical Trials, Jay Park and Rebecca Metcalfe of Core Clinical Sciences discussed their recent article published in JAMA titled, “Diversity Action Plans in Clinical Trials.” In addition to key takeaways from the article, Park and Metcalfe discussed the FDA’s new guidance for diversity action plans in clinical trials, the role of risk-based monitoring as a tool for improving diversity, and the importance of patient-reported outcomes.
Pharmacy Times interviewed Julie Sibbesen, PharmD, a clinical pharmacy specialist in Enterprise Medication Use at WVU Medicine in Morgantown, West...